Henlius Adalimumab Biosimilar reciba la aprobación por medio de la NMPA ...Middle East

SHANGHÁI, 8 de diciembre de 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) anunció que el biosimilar adalimumab HLX03, desarrollado y fabricado por la compañía de forma independiente, ha recibido la aprobación de la National Medical Products Administration (NMPA) para el...

Hence then, the article about henlius adalimumab biosimilar reciba la aprobacion por medio de la nmpa was published today ( Tuesday 08/12/2020 - 02:46 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Henlius Adalimumab Biosimilar reciba la aprobación por medio de la NMPA )

Also on site :

• Nigerian general killed in Islamic State attack
• Finn Wolfhard Told ‘Malcolm in the Middle’ Creator “F*ck Yeah” To Revival Cameo: “He’s Such A Big Fan”
• AQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026